cardiovascular innovation

FLAGSTAFF, Ariz., May 11, 2026 Corvention announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...

FORT MILL, S.C., March 6, 2026 Catheter Precision, Inc., a U.S.-based medical technology company specializing in cardiac electrophysiology innovations,...

Houston, Texas | January 2026 — HeartX, a leading cardiovascular innovation accelerator, has officially opened applications for its 2026...

Princeton, N.J., November 4, 2025 – Bristol Myers Squibb (NYSE: BMY) announced a major scientific milestone with the presentation...